Cargando…
Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial
Background Ketamine has recently become an agent of interest as an acute treatment for severe depression and as the anaesthetic for electroconvulsive therapy (ECT). Subanaesthetic doses result in an acute reduction in depression severity while evidence is equivocal for this antidepressant effect wit...
Autores principales: | Fernie, Gordon, Currie, James, Perrin, Jennifer S., Stewart, Caroline A., Anderson, Virginica, Bennett, Daniel M., Hay, Steven, Reid, Ian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Psychiatrists
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451642/ https://www.ncbi.nlm.nih.gov/pubmed/28254962 http://dx.doi.org/10.1192/bjp.bp.116.189134 |
Ejemplares similares
-
Ketamine and Electroconvulsive Therapy: Better Together?
por: Fraga, A., et al.
Publicado: (2022) -
Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials
por: Li, Xiao-Mei, et al.
Publicado: (2020) -
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial
por: Anderson, Ian M, et al.
Publicado: (2017) -
Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)
por: Finnegan, Martha, et al.
Publicado: (2016) -
Dexmedetomidine vs Propofol as an Adjunct to Ketamine for Electroconvulsive Therapy Anaesthesia
por: Yeter, Tuğçe, et al.
Publicado: (2022)